Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01659359

The Effect of Virtual Reality Glasses on Pain and Anxiety

Vice-presidency for Research

Sponsor: Mashhad University of Medical Sciences

Interventions Lidocaine Virtual reality glasses and Lidocaine

Updated 5 times since 2017 Last updated: Aug 7, 2012 Started: Jan 31, 2011 Primary completion: Jul 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01659359, this PHASE2/PHASE3 trial focuses on Pain and Anxiety and remains completed. Sponsored by Mashhad University of Medical Sciences, it has been updated 5 times since 2011, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.